Literature DB >> 1651222

Increased production of plasminogen activator inhibitor in vitro by pleural leukocytes from rats intratracheally instilled with crocidolite asbestos.

X Y Li1, G M Brown, D Lamb, K Donaldson.   

Abstract

We have previously reported that normal pleural leukocytes secrete a urokinase-type plasminogen activator inhibitor (PAI) in culture. In view of the pathogenic effects of asbestos on the pleura, in particular pleural fibrosis, we have extended these observations to crocidolite asbestos-exposed rats. Pleural leukocytes from rats exposed to crocidolite asbestos were found to secrete more PAI in culture than controls. The activity of PAI in pleural leukocyte-conditioned medium increased in a dose-dependent manner in relation to the quantity of asbestos injected into the lung. However, with increasing time post asbestos instillation, there was no significant change in the secretion of PAI by pleural leukocytes in culture compared with earlier time points of crocidolite-exposed rats. Plasminogen activator was not detectable in the conditioned medium at any time point. The data derived from this study may help to elucidate the pathogenesis of some pleural disorders caused by exposure to fibrous dusts in the lungs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651222     DOI: 10.1016/s0013-9351(05)80170-7

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  3 in total

Review 1.  New perspectives on basic mechanisms in lung disease. 5. Respirable industrial fibres: mechanisms of pathogenicity.

Authors:  K Donaldson; R C Brown; G M Brown
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

2.  Production of interleukin 1 by rat pleural leucocytes in culture after intratracheal instillation of crocidolite asbestos.

Authors:  X Y Li; D Lamb; K Donaldson
Journal:  Br J Ind Med       Date:  1993-01

3.  The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles.

Authors:  Ken Donaldson; Paul Ja Borm; Vincent Castranova; Mary Gulumian
Journal:  Part Fibre Toxicol       Date:  2009-04-27       Impact factor: 9.400

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.